Language selection

Search

Patent 1108132 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1108132
(21) Application Number: 337908
(54) English Title: PROCESS FOR PRODUCING OXYMORPHONE
(54) French Title: PROCEDE DE FABRICATION D'OXYMORPHONE
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 260/237.61
(51) International Patent Classification (IPC):
  • C07D 489/08 (2006.01)
(72) Inventors :
  • WILSON, MICHAEL L. (United States of America)
(73) Owners :
  • MALLINCKRODT, INC. (Afghanistan)
(71) Applicants :
(74) Agent: OSLER, HOSKIN & HARCOURT LLP
(74) Associate agent:
(45) Issued: 1981-09-01
(22) Filed Date: 1979-10-18
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data:
Application No. Country/Territory Date
953,056 United States of America 1978-10-19

Abstracts

English Abstract



PROCESS FOR PRODUCING OXYMORPHONE

Abstract

A process for producing oxymorphone by converting
oxycodone utilizing a suitable boron reagent in the
presence of a weak Lewis base attenuating agent.


Claims

Note: Claims are shown in the official language in which they were submitted.


-10-

WHAT IS CLAIMED:

1. A process for producing oxymorphone by reacting
oxycodone with a demethylating amount of a boron compound
selected from the group consisting of boron tribromide,
boron trichloride and the reaction product of any such
halide with a lower alcohol, in an organic solvent-
containing reaction medium under demethylating conditions,
characterized in that said reaction medium contains an
attenuating amount of an attenuating agent to attenuate
the activity of the boron compound, said attenuating agent
being a weak Lewis base which is non-reactive with said
demethylating agent, whereby oxymorphone is produced in
good yields with substantially no by-products.
2. A process according to Claim 1 characterized in
that the boron compound is used in an amount to provide
from about 2 to 8 moles of the boron compound per mole of
oxycodone and the attenuating agent is selected from the
group consisting of benzene, toluene, xylene,
ethylbenzene, nitrobenzene, chlorobenzene, diphenyl ether
and mixtures of said attenuating agents.
3. A process according to Claims 1 or 2
characterized in that the boron compound is used in an
amount to provide from about 2.5 to about 3.5 moles of the
boron compound per mole of oxycodone.
4. A process according to Claim 2 characterized in
that the boron compound is boron tribromide or boron
trichloride.
5. A process according to Claim 4 characterized in
that the attenuating agent is diphenyl ether,
chlorobenzene or toluene.
6. A process according to Claim 1 characterized in
that the oxycodone is reacted with a demethylating amount
of a demethylating composition containing said boron
compound and said attenuating agent.

-11-
7. A process according to Claim 6 characterized in
that the boron compound is boron tribromide or boron
trichloride and the attenuating agent is selected from
benzene, toluene, xylene, ethylbenzene, nitrobenzene,
chlorobenzene, diphenyl ether and mixtures of said
attenuating agents.
8. A process according to Claim 7 characterized in
that the attenuating agent is diphenyl ether,
chlorobenzene or toluene.
9. A process according to Claim 8 characterized in
that the attenuating agent is present in the demethylating
composition in an amount of about 90% by weight, based on
the total weight of the demethylating composition and the
boron compound is present in an amount of 10% by weight,
based on the total weight of the demethylating
composition.
10. A process according to Claim 9 characterized in
that the demethylating conditions include temperatures of
from about 0° to about 40°C.
11. A process according to Claim 10 characterized in
that the demethylating conditions include a reaction time
of from about 3 to about 8 hours.
12. A process for producing oxymorphone in good
yields and with substantially no by-products by
A) reacting oxycodone under demethylating conditions
with a demethylating amount of a boron compound
selected from the group consiqting of boron
tribromide, boron trichloride and the reaction
product of any such trihalide with a lower
alcohol, in an organic solvent-containing reac-
tion medium;
B) adding water to said reaction medium in an
amount sufficient to quench the demethylation
reaction;
C) hydrolyzing the reactants and reaction products
formed in said reaction medium; and

-12-


D) separating from the reaction medium the
oxymorphone produced;
characterized in that said reaction medium contains from
about 25% to 900% by weight based on said boron
demethylating agent of an attenuating agent selected from
the group consisting of benzene, toluene, xylene,
ethylbenzene, chlorobenzene, diphenyl ether and mixtures
of said attenuating agents; and further characterized in
that the hydrolysis step is conducted for a period of time
and under hydrolysis conditions sufficient to increase the
amount of recoverable oxymorphone present in the reaction
medium.
13. A process according to Claim 12 characterized in
that hydrolysis of reactants and reaction products in the
reaction medium occurs for a period of time of from about
1/2 to 10 hours and at hydrolysis temperatures of from
about 60°C to 120°C.
14. A process according to Claim 12 characterized in
that the boron compound is boron tribromide or boron
trichloride.
15. A process according to Claim 12 characterized in
that the attenuating agent is diphenyl ether, chloro-
benzene or toluene.
16. A process according to Claim 14 characterized in
that the attenuating agent is diphenyl ether, chloro-
benzene or toluene.
17. A process according to claim 15 characterized in
that hydrolysis occurs for from about 2 to 4 hours at the
reflux temperature of the reaction medium.
18. A process according to Claim 16 characterized in
that hydrolysis occurs for from about 2 to 4 hours at the
reflux temperature of the reaction medium.
19. A process according to claim 13 characterized in
that the oxycodone is reacted with a demethylating amount
of a demethylating composition containing said boron
compound and said attenuating agent.

-13-

20. A process according to claim 19 characterized in
that the boron compound is boron tribromide or boron
trichloride.
21. A process according to claim 19 characterized in
that the attenuating agent is diphenyl ether, chloro-
benzene or toluene.
22. A process according to Claim 20 characterized in
that the attenuating agent is diphenyl ether, chloro-
benzene or toluene.
23. A process according to Claim 21 characterized in
that the attenuating agent is present in the demethylating
composition in an amount of about 90% by weight, based on
the total weight of the demethylating composition and the
boron compound is present in an amount of 10% by weight,
based on the total weight of the demethylating
composition.
24. A process according to Claim 22 characterized in
that the attenuating agent is present in the demethylating
composition in an amount of about 90% by weight, based on
the total weight of the demethylating composition and the
boron compound is present in an amount of 10% by weight,
based on the total weight of the demethylating
composition.
25. A process according to Claim 23 characterized in
that the demethylating conditions include temperatures of
from about 0° to about 40°C.
26. A process according to Claim 24 characterized in
that the demethylating conditions include temperatures of
fxom about 0° to about 40°C.
27. A process according to Claim 25 or 26 charac-
terized in that the demethylating conditions include a
reaction time of from about 3 to about 8 hours.

Description

Note: Descriptions are shown in the official language in which they were submitted.


11(~8~3Z


PROCESS FO~ PRODUCING OXYMOR?HONE

This invention relates to a process for producing
oxymorphone.
Oxymorphone is a narcotic substance. It is widely
used as an analgetic. The most frequently used method for
producing oxymorphone is described by Seki, Takamlne
Kenkyisho ~e~, 12, 52 ~1960): It involves reacting
pyridine hydrochloride with oxycodone at high
temperatures. It is disadvantageous on a commercial scale
because the reaction is difficult to control, and high
temperatures are needed. Further, this reaction produces
only moderate yields along with the formation of
substantial amounts of by-products.
It is an object of this invention to provide a
process for producing oxymorphone in good yields with
substantially no by-products.
It is a further object of the present invention to
~, selectively demethylate the oxycodone methoxy group
without affecting the other sites in the oxycodone
~ 20 molecule where ether linkages can be cleaved.
; ~ In accordance with this invention, there is provided
a process for producing oxymorphone by selectively
removing the methyl group from the methoxy group of
oxycodone compr~sing reacting oxycodone with a
demethylating amount of a demethylating agent under
demethylating conditions in the presence of an attenuating
amount of an attenuating agent to attenuate the activity
of the demethylating agent, whereby oxymorphone is
produced in good yields with substantially no by-products.
30Sui,table demethylating agents are boron compounds
capable of demethylating the methoxy group but incapable
; of forming numerous by-products. Such boron compounds


. ..
~, ~

ilO813Z


include boron tribromide, boron trichloride or the
reaction product of such halides with alcohols, e.g.,
those containing 1 to 10 carbon atoms, preferably lower
alcohols such as those containing 1 to 6 carbon atoms,
S e.g., methanol, propanol, butanol, hexanol, etc.
Present in the reaction medium during the
demethylating reaction is an attenuating agent to
attenuate the activity of the boron compound such that
when utili~ed in the process of this invention, good
yields of oxymorphone are produced with substantially no
by-products. The attenuating agent can be a weak Lewis
base which does not chemically react with the
demethylating agent. Attenuating agents include normally
liquid aromatic solvents that do not chemically react with
the boron compound, e.g., benzene, toluene, xylene,
ethylbenzene, nitrobenzene, chlorobenzene, diphenyl ether
and mixtures thereof. Chlorobenzene is the preferred
attenuating agent. Attenuating amounts include from 25%
to 900% by weight based on the weight of the boron
compound.
It is preferred to utilize a demethylating
composition which contains a boron compound in an amount
sufficient to demethylate the methoxy group of oxycodone,
e.g. from about 5 to 20% preferably about 10% based on the
total weight of the demethylating composition and an
attenuating amount of an attenuating agent, e.g., 80 to
95% preferably about 90~ by weight, based on the total
weight of the demethylating composition.
Oxymorphone is reacted with the aforesaid
demethylating agent under demethylating conditions. This
includes using a demethylating amount of the demethylating
agent, e.g., in the case of boron trihalide, from about 2
to 8 moles, advantageously 2.5 to 3.5 moles, preferably
2.5 to 7 moles, of the boron compound per mole of
- 35 oxycodone. No significant advantage is achieved by using
more than 8 moles, although this is possible. Utilizing

. .. .




. ' ' , ~

13~:

less than about 2 moles may result in an incomplete
reaction. Other demethylating conditions include suitable
reaction times, e.g., 8 to 24 hours and reaction
temperatures, e.g., from about 0 to 40C. As mentioned,
s it is preferred to react oxycodone with the aforesaid
demethylating composition. Normally, the demethylating
composition is sufficiently fluid that no further solvent
is necessary to carry out the reaction. ~owever, it may
be advantageous to add a solvent, e.g., an inert solvent
that will not react with the boron compound, e.g.,
chlorobenzene. Such a solvent is preferably the same as
but can be different from the attenuating agent employed.
Alternatively, the aemethylating agent can be added
to the reaction medium separately, provided the
attenuating agent is present in a sufficient amount to
attenuate the activity of the demethylating agent. For
example, oxycodone can be mixed with the attenuating agent
to which is added the demethylating agent.
After oxycodone demethylation has occurred to the
extent desired, the demethylation reaction is quenched by
adding to the reaction medium a quenching amount of water. -
Advantageously, water is added in an amount equal to or
greater than the volume of the anhydrous reaction medium.
To maximize yield of oxymorphone, the quenched
reaction mixture is advantageously hydrolyzed for a period
of time and under hydrolysis conditions sufficient to
increase the arnount of recoverable oxymorphone present in
the reaction medium. Hydrolysis serves to hydrolyze both
excess reactants and reaction products present in the
reaction medium after demethylation. Suitable hydrolysis
step reaction times include hydrolysis for from about 1/2
to 10 hours, preferably from 2 to 4 hours. Suitable
temperatures for the hydrolysis step range from about 60~C
to 120C, preferably from about 80C to 100C. It has ~
been found that hydrolyzing the reaction mixture at higher
temperatures, e.g. at the reflux temperature of the
, ~

~Q813Z

--4--

reaction mixture, is especially advantageous, particularly
when the preferred chlorobenzene attenuatiny agent/solvent
is employed. Without being bound by any particular
theory, it is believed that hydrolysis at higher
temperatures promotes hydrolysis of those reaction
products in the form of boron complexes such as complexes
containing a boron-nitrogen bond, thereby converting more
of such complexes into recoverable oxymorphone. Higher
hydrolysis temperatures may also serve to convert other
reaction by-products present into recoverable product.
After hydrolysis, the pH of the reaction mixture is
adjusted to about 4.5 to about 6 with acid, e.g.,
hydrochloric or sulfuric, filtered and then adjusted with
a suitable base, e.g., sodium hydroxide, to a pH of about
lO to 12 and extracted with one of the conventional inert
organic extraction solvents, e.g., toluene. The aqueous
layer is then adjusted to a pH of about 2 with acid and
then to about 8.5 with base and extracted with an inert
organic extraction solvent, e.g., methylene chloride,
which is evaporated to give oxymorphone substantially free
; of impurities. The first organic extract is evaporated to
give oxycodone suitable for recycle.
The following examples illustrate the invention. All
parts are by weight unless otherwise stated.

EXAMPLE l

A slurry of 25g of oxycodone base in 200ml of
chlorobenzene is placed in a vessel equipped for efficient
stirring and the contents are cooled to less than 10C. A
solution of 60g of borontribromide is prepared in 200ml of
chlorobenzene and this solution is added over a span of 5
minutes to the oxycodone slurry. The temperature rises to
about 35C. The cooling is removed and the mixture is
stirred for 18 hours. At this point the mixture is poured
into 250ml of water and the mixture is refluxed for 2
hours. The aqueous and organic layers are separated and


,~


::


~, .

813Z

--5--

the aqueous layer is assayed for oxycodone and
oxymorphone. The aqueous layer is adjusted to a pH of 5.5
with sodium hydroxide or ammonia and filtered. The
filtrate is adjusted to a pH of 12 with sodium hydroxide
and exhaustively extracted with methylene chloride. The
methylene chloride layer is separated and evaporated to
give oxycodone which can be recycled. The aqueous layer
is acidified with hydrochloric acid to a pH of 2.0 and
then adjusted to a pH of 8.5 with ammonia and exhaustively
extracted with methylene chloride. The organic layer is
evaporated to give substantially pure oxymorphone.
Data for this experiment are shown in the following
Table I as well as that obtained for other solvents
following substantially the same procedure.

TABLE I
Run # Solvent Mole BBr Yield

1 Chlorobenzene 3 76%
2 Toluene 3 82% (9~ oxycodone
recovered)
3 CHC13 4 66%
20 4 CH2C12 4 51%
CHC13 6 51%
6 Ethylene 4 29%
Dichloride
7 S-tetrachloro 4 65%
ethane

BXAMPLE 2

A slurry of 1.5 g of oxycodone in benzene is treated
all at once with 2.3g of boron tribromide in benzene and
the mixture stirred for 2 hours, the mixture was
hydrolyzed with an equal volume of water at reflux for 2
hours. The aqueous layer was assayed to indicate an 85
yield of oxymorphone and a 15% yield of oxycodone.
By essentially following the procedure of Example 2
the data in Table II was obtained.
: .

.

- - - ~

~: :

1~8~3Z
_ .
~ 6 --

_ABLE II
Run # Solvent Moles BBr3 Yield
l CHCl3/Toluene 4 70%
1:1
2 Toluene 4 76% (15% oxycodone
recovered) :~
3 Toluene 6 50%
4 Toluene 3 85% (5~ oxycodone
recovered)
Toluene 2 62% (10~ oxycodone
recovered)
10 6 Toluene l 23% (68% oxycodone
recovered)
7 Xylene 3 81% (6% oxycodone
recovered)
8 Chlorobenzene 3(BC13) 70~
: EXAMPLE 3 ~-
Using the following general procedures, oxycodone is de-
methylated to form oxymorphone using a boron tribromide demethyla-
ting agent. Variations in boron tribromide/oxycodone ratio, type
of reaction medium organic solvent employed and hydrolysis condi-
tions are set forth in Table III:
Boron tribromide in solvent is added to a slurry of oxy-
codone in solvent for Runs 5-8, with the reaction medium tempera-
. ture being maintained below about 10C. The order of addition is ::
: reversed for Runs 1-4. After reaction times varying from l to 20 ;:
hours, the reaction mixture is quenched by addition of water. Hy- :~
drolysis of the reaction mixture then takes place either at 40C
or at reflux temperature of the reaction medium. The pH of the
reaction mixture is then adjusted to about 5.5, and the reaction
mixture is analyzed for oxymorphone conversion using liquid
chromatography techniques.
' ~
.

.,: , . . . -
.. .. . . .

: ' . . ~ ' . :~
: : , .

3,111813Z

c: - 7-
O
O C
ra S~ ~ O
~ ~ ~ ~ L~ ~.0 oa co r`
~0

.,,
~1~ X ~ X ~ ~
O ~ o ~ o ~ ~ ~ o o
::~. S~ h h h
X . ' .,.

r~
~,) V C~ N N
ol o ~ o o m m m m

~_
U~
~0 ~
U
a~ ~
: H
H ra~ ~ ~ ~ ~D ~) ~O
~D ' U
Q C O
O
~q
.' ~0 .
O ~

O Q)

o
- o


~_U~ O U~
~~ ~ ~ ~ `9 '`
m
. - m . .
.
Z ~ .




.

3Z

--8--

The above table III data illustrate that oxymorphone
yield is improved by utilizing the chlorobenzene solvent/
attenuating agent and by utilizing hot hydrolysis
conditions.
EXAMPLE 4
Approximately 2.68kg of oxycodone are added to a 189
liter reaction vessel furnished with a heating/cooling
jacket, said vessel containing 48kg of chlorobenzene. The
contents of the reaction vessel are rapidly stirred and
the system is purged with nitrogen. About 7.8kg of boron
tribromide are added to the mixture over a period of 20-30
minutes during which time the temperature of the reaction
mixture is kept below 25C.
Upon completion of the boron tribromide addition, the
lS contents of the reaction vessel are stirred for 6 hours at
room temperature (25-28C). At this point the reaction
mixture is pumped with stirring to a 246 liter vessel
containing 32.66kg of water which has been cooled to less
than 10C. The addition process is such that the vessel
temperature remains below 30C.
The resulting slurried mixture is pumped back into
the 189 liter reaction vessel and is heated to reflux
(96C) with slow stirring so as to prevent emulsion forma-
tion. After two hours of refluxing, the reaction vessel
contents are cooled to 60-80C and the layers are allowed
to separate. Upon separation the bottom aqueous layer is
removed and the organic layer is rinsed-with 5.67kg of
de-ionized water and slowly stirred. As the mixture
settles, the layers switch so that the aqueous layer
becomes the top layer. The aqueous layer is removed and
combined with the previous aqueous extraction.
The pH of the organic layer is adjusted to 5.5-6.0
with ammonium hydroxide. About 0.45-0.9kg of darco
- (activated carbon; Darco G-60; Darco is a registered U.S.
trademark of Atlas Powder Company for a line of activated
carbons of which "G-60" is a highly activated grade for
drug/chemical purification) are added and the resulting
~;
, ,,, ~,, .


.
,
~. ' . .
~ .

313~

g

mixture is filtered and then washed with 3.8-7.6 liters of de-
ionized water. The pH is readjusted to 8.8-8.9 with ammonium
hydroxide. The resulting aqueous slurry is extracted with di-
chloromethane in a continuous Karr column extractor until the
aqueous portion contains less than 1.5 mg of oxymorphone per ml.
The dichloromethane portion is backwashed with 2 3.8 liter por-
tions of de-ionized water and is returned to a 189 liter reac-
tion vessel having a heating/cooling jacket which is maintained
at 70-80C. The dichloromethane solution is stripped to dryness
and the last of the dichloromethane and residual water is removed
under vacuum. About 30 liters of anhydrous ethanol are added to
the reaction vessel whereupon the resulting mixture is warmed
to 65-70C. The mixture is filtered if necessary and the eth-
anol mixture is then cooled with stirring to less than 10C.
The resulting crystallization product is filtered and dried at
65-75C for 2-4 hours to give 1.36-1.59 kg of oxymorphone.
The filtrate is stripped to near dryness and is repla-
ced with 7.57 liters of de-ionized water. The pH is adjusted to
less than 5.0 and ls subsequently readjusted to 8.5-8.8 with
ammonium hydroxide while maintaining the temperature of the mix-
ture at less than 30C. The mixture is cooled to 10-15C and
the resulting precipitated solid is filtered and washed with two
0.95 liter portions of water at 10-15C. The solid is dried at
70-80C for a minimum of 6 hours to give 0.36 to 0.5 kg of resi-
due as additional oxymorphone-containing product.
EXAMPLE 5
- Preparation of Oxymorphone with Recovery of Unreacted Oxycodone

Oxycodone (50 g) in 400 ml of chlorobenzene is cooled




',

:

~1~?813Z

- 9a -


to 8C and treated with 120 g of BBr3 in 400 ml of chlorobenzene,
over 10 minutes. The reaction medium is stirred for one hour at
room temperature and is then added to 500 ml of ice water. The
mixture is heated to reflux. The aqueous layer is then cooled
and separated, and adjusted to a pH of 5.5 with ammonia. Acti-
vated charcoal is added, and the liquid is filtered with Celite.
The pH is then adjusted to 8.5 with ammonia. The aqueous layer
is then exhaustively extracted with methylene chloride.
The methylene chloride layer is extracted with diluted
sodium hydroxide solution. The aqueous layer is then adjusted
to a pH of 4 and then 8.5, and the precipitated oxymorphone is
collected by filtration. The methylene chloride layer is ex-
tracted with lN.HCl. The resulting aqueous layer is treated
with ammonia to give a precipitate of oxycodone.
Altogether, 27.2 g of oxymorphone and 7.1 g of oxyco-
done are recovered.




: :




,


Representative Drawing

Sorry, the representative drawing for patent document number 1108132 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1981-09-01
(22) Filed 1979-10-18
(45) Issued 1981-09-01
Expired 1998-09-01

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1979-10-18
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
MALLINCKRODT, INC.
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1994-03-18 1 7
Claims 1994-03-18 4 177
Abstract 1994-03-18 1 8
Cover Page 1994-03-18 1 13
Description 1994-03-18 10 402